Strategies to Combat Multi-Drug Resistance in Tuberculosis-Reference-Cited by-同舟云学术

Strategies to Combat Multi-Drug Resistance in Tuberculosis

Published:2021-04-22 Issue:10 Volume:54 Page:2361-2376
ISSN:0001-4842
Container-title:Accounts of Chemical Research
language:en
Short-container-title:Acc. Chem. Res.

Author:

Singh Vinayak¹²^ORCID,Chibale Kelly¹²^ORCID

Affiliation:

1. Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa

2. South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa

Funder

Bill and Melinda Gates Foundation

National Research Foundation

South African Medical Research Council

South African Department of Science

Innovation/ National Research Foundation

Technology Innovation Agency

Strategic Health Innovation Partnerships (SHIP) unit of the SAMRC

Publisher

American Chemical Society (ACS)

Subject

General Medicine,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.accounts.0c00878

Reference40 articles.

1. Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration

2. Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies

3. Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies

4. Synthesis, Structure–Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity

5. Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiadiazole-thiazole derivatives as potent anti-tubercular agents: Synthesis, biological evaluation, and In silico docking studies;European Journal of Medicinal Chemistry Reports;2024-12

2. The rv2820c K114N mutation is related with capreomycin tolerance;Tuberculosis;2024-09

3. Halogenated chalcones against Mycobacterium tuberculosis targeting InhA: rational design, in silico and in vitro evaluation;Microbial Pathogenesis;2024-09

4. The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐TB Drugs—A Perspective;Chemical Biology & Drug Design;2024-09

5. Anti-mutagenic agent targeting LexA to combat antimicrobial resistance in mycobacteria;Journal of Biological Chemistry;2024-09